All Emma Walmsley articles
-
Business
GSK stops over 30 research programmes to prioritise innovation
New boss Emma Walmsley outlines sweeping changes in order to focus on high-return drug projects
2017-08-04T14:05:00Z
New boss Emma Walmsley outlines sweeping changes in order to focus on high-return drug projects
Site powered by Webvision Cloud